ArticleBritish journal of haematology2017

Anti-leukaemic activity of the TYK2 selective inhibitor NDI-031301 in T-cell acute lymphoblastic leukaemia.

Koshi Akahane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.